Showing results (601-610 of 1,464) with videos related to

Sort By:
Pageof 147
Medcomm|March 28, 2025
Identifying the Intergenic ALK Fusion LOC388942-ALK as a Driver of Non-Small Cell Lung CancerXiaoqian Zhai, Manli Wang, Qi Zhang, et al.
Medcomm|February 27, 2026
RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic TargetsXuan Yin, Zengkan Du, Shuya Jiang, et al.
Medcomm|February 27, 2026
LKB1-AMPK Signaling Pathway in Cardiovascular and Other DiseasesZhuo Chen, Qin Yang, Guo-Wei He
Medcomm|March 9, 2026
The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic OpportunitiesChan Zou, Shilong Jiang, Hui Li, et al.
Medcomm|March 4, 2026
Bacteriophage Therapy: Current Strategies and Future PerspectivesZihe Zhou, Hanyu Fu, Mengzhe Li, et al.
Medcomm|May 30, 2023
RAS-targeted cancer therapy: Advances in drugging specific mutationsCen Liu, Danyang Ye, Hongliu Yang, et al.
Medcomm|February 6, 2024
Correction to: Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK-IDH2 pathwayHao Huang, Shuai Guo, Ya-Qin Chen, et al.
Medcomm|March 25, 2024
cGAS-STING, an important signaling pathway in diseases and their therapyQijie Li, Ping Wu, Qiujing Du, et al.
Medcomm|February 12, 2024
Stromal interaction molecule 1/microtubule-associated protein 1A/1B-light chain 3B complex induces metastasis of hepatocellular carcinoma by promoting autophagyJingchun Wang, Qichao Xie, Lei Wu, et al.
Medcomm|March 11, 2024
A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response scoreXinlong Zheng, Tao Lu, Shiwen Wu, et al.
Pageof 147